Study: Healthcare isn’t as consumer centric as it wants to be
Prophet surveyed 240 healthcare organizations to find out where the industry is actually at on its shift to consumer centricity.
Corporate
Purdue’s sales force targeted high prescribers with a ‘false narrative,’ unsealed lawsuit says
Directing its reps to call on GPs with little to no opioid experience, Purdue introduced aggressive promotional tactics into the prescription opioid marketing playbook.
Did the market overreact to Biogen’s Alzheimer’s data?
Biogen’s recently soaring stock price can be attributed to investor optimism in one of the most stubborn areas of drug development.
MSLs: ‘We are the connectors’
Meet “the connectors” as four of the best-regarded medical science liaisons and the leader of the MSL Society discuss what they do, how they do it, and why their work is so vital.
Merck’s Keytruda continues its string of blockbuster results, but BMS’ Opdivo still leads in sales
Although analysts predict this dynamic won’t last long.
The story behind Sanofi’s tweet: ‘Using our medicines as a crutch for bad behavior is not appropriate’
Why Sanofi felt “obligated” to respond to Roseanne Barr’s claim of “Ambien tweeting.”
Ambien maker Sanofi’s response to Roseanne: ‘Racism is not a side effect’
The drugmaker clapped back to Roseanne Barr’s comment that she was “Ambien tweeting” when she made racist remarks about Valerie Jarrett.
Biden Initiative’s Greg Simon: Innovation comes when health system collaborates
The president of the Biden Cancer Initiative shared lessons learned from the White House Cancer Moonshot.
‘Not a good day for Novartis’: how the Novartis-Cohen crisis unfolded
Here’s a recap of the Novartis-Michael Cohen crisis, which unfolded this week, including how the drugmaker has responded to scrutiny over its $1.2 million contract with Cohen’s firm.
GSK reviews $1.76 billion global media
Pharma giant GlaxoSmithKline has reportedly launched a review of its $1.76 billion global media agency arrangements, putting MediaCom and PHD on alert.
Want to read more?
Please login or register first to view this content.
